Epigenetic Regulation of Kidney Fibrosis following AKI
AKI 后肾脏纤维化的表观遗传调控
基本信息
- 批准号:10413226
- 负责人:
- 金额:$ 42.64万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-06-01 至 2025-03-31
- 项目状态:未结题
- 来源:
- 关键词:AcuteAcute Renal Failure with Renal Papillary NecrosisAdverse eventAtrophicAttenuatedBilateralBlood VesselsBlood flowCardiacCell NucleusCellsCessation of lifeChromatinChronicChronic Kidney FailureCicatrixComplement Factor BCoupledDataDevelopmentDisease ProgressionElectrolytesEndothelial CellsEndotheliumEnzymesEpigenetic ProcessEpithelialEpithelial CellsFibroblastsFibrosisFosteringGenesHDAC1 geneHistone DeacetylaseHistone Deacetylase InhibitorImmuneIn VitroInjuryInjury to KidneyKidneyKidney DiseasesKnock-outKnockout MiceKnowledgeLeadLiquid substanceMediatingMicroRNAsModelingModificationMolecularMyofibroblastOperative Surgical ProceduresOutcomePathologicPathway interactionsPatientsPatternPericytesProtein IsoformsProteinsPublishingRenal functionReperfusion InjuryRiskSignal PathwaySignal TransductionSourceStructure of glomerular mesangiumTestingTherapeuticTransforming Growth FactorsTubular formationUp-RegulationUreteral obstructionattenuationbeta catenincell typedifferential expressionepigenetic regulationepithelial repairexperimental studyglomerulosclerosishealinghypoperfusionin vivointerstitialinterstitial cellkidney cellkidney cortexkidney fibrosisknock-downmouse modelnovelnovel therapeutic interventionpreventrepairedresponsetranscriptome sequencingtranscriptomics
项目摘要
SUMMARY
Episodes of acute kidney injury (AKI) are associated with an increased risk for chronic kidney
disease (CKD); a permanent loss of kidney function. Following AKI, crosstalk between epithelial
and interstitial cells is critical for kidney healing (adaptive response) but if prolonged fosters CKD
(maladaptive). Evidence suggests that epigenetic modifiers, such as histone deacetylases
(HDACs) and microRNAs (miRs), can become deranged leading to pathological conditions. For
example, activation of kidney HDACs following AKI is hypothesized to exacerbate injury; however,
we and others have demonstrated that HDACs are also necessary for epithelial repair. A gap in
our knowledge exists in the kidney cell type specific, HDAC isoform-dependent mechanisms of
repair or chronic injury in response to AKI. We identified that following AKI, HDAC1 is significantly
increased in the kidney cortex including in fibroblasts and pericytes. Utilizing inducible, fibroblast-
specific HDAC1 knockout (KO) mice, we found that fibroblast/pericyte HDAC1 results in
myofibroblast activation and fibrosis. One potential target of HDAC1 may be miR-215-5p
(miR215). miR215 is reduced by in vivo HDAC inhibition, and is increased by HDAC1 in kidney
fibroblast/pericyte cells. We provide data that fibroblast miR215 is profibrotic. From these data,
we propose to test the following hypotheses: Aim 1: To test the hypothesis that AKI-mediated
fibrosis is dependent on activation of fibroblast/pericyte cell HDAC1. Aim 2: To test the
hypothesis that AKI promotes miR215 dependent interstitial fibrosis in the kidney. The
experiments proposed in this R01 will provide deep molecular evidence of epigenetic regulation
of the kidney fibroblast/pericytes following AKI and we will determine the dynamic epigenetic
patterning during CKD transition. Using both biased and unbiased approaches will result in the
identification of novel pathways that likely be of therapeutic value to help attenuate AKI-CKD
transition.
概括
急性肾损伤 (AKI) 发作与慢性肾损伤风险增加相关
疾病(慢性肾病);肾功能永久性丧失。 AKI 后,上皮细胞之间的串扰
间质细胞对于肾脏愈合(适应性反应)至关重要,但如果时间延长会导致 CKD
(适应不良)。有证据表明表观遗传修饰剂,例如组蛋白脱乙酰酶
(HDAC) 和 microRNA (miR) 可能会变得混乱,导致病理状况。为了
例如,假设 AKI 后肾脏 HDAC 的激活会加剧损伤;然而,
我们和其他人已经证明 HDAC 对于上皮修复也是必需的。差距在
我们的知识存在于肾细胞类型特异性、HDAC 异构体依赖性机制中
针对 AKI 的修复或慢性损伤。我们发现 AKI 后,HDAC1 显着
肾皮质(包括成纤维细胞和周细胞)增加。利用诱导型成纤维细胞
在特定 HDAC1 敲除 (KO) 小鼠中,我们发现成纤维细胞/周细胞 HDAC1 导致
肌成纤维细胞活化和纤维化。 HDAC1 的一个潜在靶点可能是 miR-215-5p
(miR215)。 miR215 因体内 HDAC 抑制而减少,并因肾脏中的 HDAC1 而增加
成纤维细胞/周细胞。我们提供的数据表明成纤维细胞 miR215 具有促纤维化作用。从这些数据来看,
我们建议检验以下假设: 目标 1:检验 AKI 介导的假设
纤维化依赖于成纤维细胞/周细胞 HDAC1 的激活。目标 2:测试
假设 AKI 促进肾脏中 miR215 依赖性间质纤维化。这
本 R01 中提出的实验将为表观遗传调控提供深层分子证据
AKI 后肾成纤维细胞/周细胞的变化,我们将确定动态表观遗传
CKD 过渡期间的图案化。同时使用有偏见和无偏见的方法将导致
鉴定可能具有治疗价值的新途径,有助于减轻 AKI-CKD
过渡。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kelly Hyndman其他文献
Kelly Hyndman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kelly Hyndman', 18)}}的其他基金
Deep South KUH Premier Research- Interdisciplinary Mentored Education (PRIME) Networking Core
深南 KUH 顶级研究 - 跨学科指导教育 (PRIME) 网络核心
- 批准号:
10724929 - 财政年份:2023
- 资助金额:
$ 42.64万 - 项目类别:
Lysine Acetylation and the Regulation of Vasopressin/Aquaporin System in the Principal Cell
主细胞中赖氨酸乙酰化和加压素/水通道蛋白系统的调节
- 批准号:
10175553 - 财政年份:2021
- 资助金额:
$ 42.64万 - 项目类别:
Epigenetic Regulation of Kidney Fibrosis following AKI
AKI 后肾脏纤维化的表观遗传调控
- 批准号:
10625369 - 财政年份:2021
- 资助金额:
$ 42.64万 - 项目类别:
Epigenetic Regulation of Kidney Fibrosis following AKI
AKI 后肾脏纤维化的表观遗传调控
- 批准号:
10295288 - 财政年份:2021
- 资助金额:
$ 42.64万 - 项目类别:
Lysine Acetylation and the Regulation of Vasopressin/Aquaporin System in the Principal Cell
主细胞中赖氨酸乙酰化和加压素/水通道蛋白系统的调节
- 批准号:
10662292 - 财政年份:2021
- 资助金额:
$ 42.64万 - 项目类别:
Lysine Acetylation and the Regulation of Vasopressin/Aquaporin System in the Principal Cell
主细胞中赖氨酸乙酰化和加压素/水通道蛋白系统的调节
- 批准号:
10445263 - 财政年份:2021
- 资助金额:
$ 42.64万 - 项目类别:
Novel mechanisms of HDAC1 regulation of renal collecting duct function
HDAC1调节肾集合管功能的新机制
- 批准号:
9766242 - 财政年份:2015
- 资助金额:
$ 42.64万 - 项目类别:
Novel mechanisms of HDAC1 regulation of renal collecting duct function
HDAC1调节肾集合管功能的新机制
- 批准号:
8868322 - 财政年份:2015
- 资助金额:
$ 42.64万 - 项目类别:
相似海外基金
Real-time Prediction of Adverse Outcomes After Surgery
实时预测手术后不良后果
- 批准号:
10724048 - 财政年份:2023
- 资助金额:
$ 42.64万 - 项目类别:
Mechanisms of subclinical renal injury in females following AKI: implications for adverse pregnancy outcomes
AKI 后女性亚临床肾损伤的机制:对不良妊娠结局的影响
- 批准号:
10568101 - 财政年份:2023
- 资助金额:
$ 42.64万 - 项目类别:
A Randomized Clinical Trial of the Safety and FeasibiLity of Metformin as a Treatment for sepsis induced AKI (LiMiT AKI)
二甲双胍治疗脓毒症引起的 AKI (LiMiT AKI) 的安全性和可行性的随机临床试验
- 批准号:
10656829 - 财政年份:2023
- 资助金额:
$ 42.64万 - 项目类别:
Wearable alert system for detecting postoperative hypotension
用于检测术后低血压的可穿戴警报系统
- 批准号:
10760370 - 财政年份:2023
- 资助金额:
$ 42.64万 - 项目类别:
Multiple Chronic COnditions: MultiPle dAta SouRcEs (MC COMPARE)
多种慢性病:多种数据源(MC COMPARE)
- 批准号:
10726452 - 财政年份:2023
- 资助金额:
$ 42.64万 - 项目类别: